Adverse drug reactions are the 4th leading cause of death in the US. 30–60% are preventable with pharmacogenomic testing. Your DNA determines which medications help, which do nothing, and…
23andMe filed for bankruptcy, was acquired by TTAM Research Institute, and your DNA is under new ownership. What happened, what it means for your data, and what to do about it.
Your CYP1A2 gene determines whether coffee protects your heart or strains it. Your ACTN3 gene shapes whether you're built for sprints or marathons. Welcome to nutrigenomics — where diet…
The average rare disease diagnosis takes 5-8 years. Some families wait 30. Whole genome sequencing is replacing years of sequential testing with a single, comprehensive answer.
Our honest Sequencing.com review covers the $399 whole genome sequencing kit, the DNA app marketplace, hidden costs, data delivery, and how it compares to Dante Labs and DNA Complete in…
The APOE gene is the strongest genetic risk factor for late-onset Alzheimer's. Learn what e2, e3, and e4 alleles mean for your brain health, cardiovascular risk, and what you can actually…
The alcohol flush reaction is caused by an ALDH2 variant carried by hundreds of millions of people. It's more than a red face — it's linked to cancer risk.
Alpha-1 antitrypsin deficiency is frequently misdiagnosed as ordinary COPD or asthma for years. Knowing your SERPINA1 status changes prevention and treatment.
CYP2C19 and CYP2D6 shape how your body handles many antidepressants. Genetics won't pick the drug for you, but it can explain side effects and dosing.
A 32-base-pair deletion in CCR5 blocks the doorway most HIV uses to enter cells. It's the basis of the only confirmed HIV cures — and a cautionary gene-editing tale.
Your natural sleep timing is partly heritable, shaped by clock genes like PER2, PER3 and CLOCK. A rare variant even causes lifelong extreme early rising.
Clopidogrel needs CYP2C19 to activate. Poor metabolizers get little benefit — an FDA boxed-warning issue that genetic testing can flag before a stent fails.
A DPYD variant can make routine fluoropyrimidine chemotherapy fatal. Regulators now recommend testing before treatment — here's why it matters and who should ask.
Eye color isn't a single dominant-recessive gene. OCA2 and HERC2 lead a polygenic system that makes inheritance far more interesting than the textbook version.
Factor V Leiden is the most common inherited clotting disorder, carried by around 1 in 20 people of European descent. Here's what it means for surgery, pregnancy, and travel.
FH affects roughly 1 in 250 people and is dramatically underdiagnosed. A genetic answer can reshape how aggressively your cholesterol is treated — decades earlier.
Hemochromatosis from HFE C282Y variants is one of the most common inherited disorders in people of European descent — and one of the most treatable. Here's what your genome can tell you.
Whether you can digest lactose as an adult comes down to a single regulatory variant near the LCT gene — and it's one of the clearest examples of recent human evolution.
Long QT syndrome affects roughly 1 in 2,000 people and can cause fainting or sudden cardiac death — often in young, otherwise-healthy individuals. Genetics can flag it.
The AR gene on the X chromosome matters, but hair loss is highly polygenic. Here's what genome data can and can't tell you about going bald.
The UK, US and others are piloting whole genome sequencing at birth to screen for hundreds of treatable conditions. Here's where the science stands in 2026.
LRRK2 and GBA are the two most important genes in Parkinson's risk. Here's what carrying a variant does — and doesn't — mean, and why penetrance matters.
A single SLCO1B1 variant markedly raises statin exposure and the risk of muscle side effects. CPIC has published dosing guidance based on it.
TCF7L2 is the strongest common genetic risk factor for type 2 diabetes. But it's one of the most modifiable — lifestyle changes work even harder for carriers.
VKORC1 and CYP2C9 together explain a large share of the huge person-to-person variation in warfarin dose. Genotype-guided dosing is FDA-labeled.
Exome sequencing reads ~1-2% of your genome; whole genome reads it all. Here's exactly what each catches, what each misses, and when the price gap is worth it.
The COMT Val158Met polymorphism determines how fast your brain clears dopamine. Learn what warrior vs. worrier really means, what rs4680 says about stress, focus, and pain — and what the…
AncestryDNA, 23andMe, FamilyTreeDNA, MyHeritage, and whole genome sequencing compared honestly. Which ancestry DNA test is actually worth your money in 2026?
An honest, independent review of Dante Labs whole genome sequencing in 2026. Pricing, raw data access, turnaround times, and what 100,000+ genomes taught us about this provider.
Why whole genome sequencing matters in 2026: from pharmacogenomics to rare disease detection, here are 10 evidence-based reasons to decode your complete DNA.
Whole genome sequencing vs genotyping: a data-driven comparison of what each approach captures, what it misses, and which delivers better value per dollar in 2026.
99% of people carry at least one pharmacogenomic variant. Here's why your genes affect how drugs work in your body — and how genome testing can prevent dangerous reactions.
Got your genome sequenced? Here's how to analyze your raw DNA data using free and paid tools — from Promethease to SelfDecode to open-source bioinformatics pipelines.
Can genome testing predict cancer? A careful look at hereditary cancer genes beyond BRCA, what WGS detects that genotyping misses, and the limits of genetic risk assessment.
Which genome testing services ship internationally? A guide for buyers in Europe, Latin America, Asia, and beyond — covering providers, legal restrictions, and shipping logistics.
What are FASTQ, BAM, and VCF files? A plain-language guide to the three raw data formats you get from whole genome sequencing — what they contain, how big they are, and what to do with them.
A major FDA rule that would have reshaped genetic testing oversight was vacated by a federal court in 2025, and the FDA chose not to appeal. Here's what that means for consumers in 2026.
23andMe vs Dante Labs: one reads 0.01% of your genome for $229, the other reads 100% for $180. A detailed comparison of coverage, data, reports, and real-world value.
Who owns your genome data? A provider-by-provider comparison of DNA data privacy policies, deletion rights, third-party sharing, and what happens when a company goes bankrupt.
The MTHFR gene explained with science, not hype. What C677T and A1298C variants do, how they affect folate metabolism, and what the evidence actually says about supplementation.
30× coverage explained in plain language: why your genome needs to be read 30 times, what Q30 scores mean, and why coverage depth determines whether your results are clinical-grade.
Genome sequencing costs in 2026: from $79 genotyping tests to $430 whole genome sequencing, here's what every provider charges and what you actually get for your money.
Dante Labs vs Sequencing.com: a head-to-head comparison of the two leading consumer whole genome sequencing providers — pricing, raw data, turnaround, and reliability.
A step-by-step guide to pre-conception genetic testing for couples. What carrier screening is, how to get tested, how to read results, how to find a genetic counselor, and what your options…